UK markets open in 2 hours 37 minutes

American Oncology Network, Inc. (AONC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.9600+0.2600 (+15.29%)
At close: 04:00PM EDT
1.9400 -0.02 (-1.02%)
After hours: 06:25PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 20.01M
Enterprise value 108.50M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.02
Price/book (mrq)N/A
Enterprise value/revenue 0.08
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-80.88%
S&P500 52-week change 327.84%
52-week high 339.6000
52-week low 31.5000
50-day moving average 34.6642
200-day moving average 36.9378

Share statistics

Avg vol (3-month) 321.51k
Avg vol (10-day) 368.09k
Shares outstanding 510.21M
Implied shares outstanding 610.21M
Float 81.56M
% held by insiders 141.57%
% held by institutions 11.14%
Shares short (30 Apr 2024) 421.29k
Short ratio (30 Apr 2024) 41.52
Short % of float (30 Apr 2024) 40.43%
Short % of shares outstanding (30 Apr 2024) 40.17%
Shares short (prior month 28 Mar 2024) 425.56k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.89%
Operating margin (ttm)-5.18%

Management effectiveness

Return on assets (ttm)-5.52%
Return on equity (ttm)-102.05%

Income statement

Revenue (ttm)1.34B
Revenue per share (ttm)156.42
Quarterly revenue growth (yoy)20.00%
Gross profit (ttm)N/A
EBITDA -24.73M
Net income avi to common (ttm)-15.48M
Diluted EPS (ttm)-2.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)105.05M
Total cash per share (mrq)13.95
Total debt (mrq)127.36M
Total debt/equity (mrq)226.99%
Current ratio (mrq)1.38
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)27.35M
Levered free cash flow (ttm)66.87M